hVIVOOPORF +27.29%43 Days Inventory is 0.00 as of Dec. 2025. GuruFocus rates OPORF with a GF Score™ of 43/100 and a GF Value™ of $0.25 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 176 Medical Diagnostics & Research companies, hVIVO ranks better than 85.23% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). hVIVO's Average Total Inventories for the
six
months ended in Dec. 2025 was $1.66 Mil. hVIVO's Cost of Goods Sold for the
six
months ended in Dec. 2025 was $-4.09 Mil.
The historical rank and industry rank for hVIVO's Days Inventory or its related term are showing as below:
OPORF'
s Days Inventory Range Over the Past 10 Years
Min: 14.09 Med: 305.49 Max: 478.47
Current: 20.44
During the past 13 years, hVIVO's highest Days Inventory was 478.47. The lowest was 14.09. And the median was 305.49.
OPORF's Days Inventory is ranked better than 85.23% of 176
companies
in the Medical Diagnostics & Research industry
Industry Median: 68.88
vs OPORF: 20.44
hVIVO's Days Inventory
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
hVIVO's Inventory Turnover for the
six
months ended in Dec. 2025 was -2.47.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
hVIVO's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.05.
hVIVO (OTCPK:OPORF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
hVIVO's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
hVIVO's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
hVIVO Days Inventory Related Terms
hVIVO Days Inventory Historical Data
* Premium members only.
The historical data trend for hVIVO's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OPORF vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, hVIVO's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
hVIVO Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, hVIVO's Days Inventory distribution charts can be found below:
* The bar in red indicates where hVIVO's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
hVIVO (OPORF) has a Days Inventory of 0.00 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on hVIVO and its competitors. Over the past decade, hVIVO's Days Inventory has ranged from 14.09 to 478.47. According to the industry distribution chart, hVIVO ranks #26 out of 176 companies in the Medical Diagnostics & Research industry, placing it in the top 14.8%.
Is hVIVO's Days Inventory too high?
hVIVO's current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 14.09 to a high of 478.47. Based on the distribution chart, hVIVO ranks #26 out of 176 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, hVIVO has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does hVIVO's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, hVIVO ranks #26 out of 176 companies for Days Inventory. This places hVIVO in the top 15% of its industry — outperforming the majority of peers. The industry median Days Inventory is 68.88. Historically, hVIVO's own Days Inventory has ranged from 14.09 to 478.47 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 68.88, based on 176 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on hVIVO and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 68.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. hVIVO's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is hVIVO stock overvalued right now?
Based on GuruFocus' analysis, hVIVO (OPORF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.25, compared to a current price of $0.11 — trading 56.2% below its estimated fair value. The current Days Inventory is 0.00. hVIVO's overall GF Score™ is 43/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For hVIVO (OPORF), the current Days Inventory is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is hVIVO (OPORF) Overvalued in 2026?
Based on GuruFocus' analysis, hVIVO stock appears to be undervalued.
The current stock price of $0.11 is trading 56.2% below its estimated GF Value™ of $0.25.
GuruFocus considers hVIVO to be Possible Value Trap.
Key valuation signals for OPORF:
Days Inventory: 0.00
GF Value™: $0.25 vs. price of $0.11 (56.2% below fair value)
No single metric tells the full story. See the OPORF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
hVIVO PLC is a full-service early phase Contract Research Organisation (CRO). It delivers end-to-end clinical development services to a diverse and expanding client base. The group specialises in conducting human challenge trials across multiple infectious and respiratory indications. It also offers comprehensive virology and immunology laboratory services under the hLAB brand. Through its subsidiary, it provides early-phase clinical trial services and Early Drug Development Consulting and Biometry services to the biopharma sector. It provides development solutions from preclinical stages through Phase II trials, via FluCamp. Geographically, the company generates maximum revenue from Europe, followed by North America, the United Kingdom, and Asia.
43GF Score
Get the complete analysis for OPORF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPORF has been successfully added to your 
